[HTML][HTML] Advanced cutaneous squamous cell carcinoma management in immunotherapy era: achievements and new challenges
L Lorini, A Alberti, P Bossi - Dermatology Practical & Conceptual, 2023 - ncbi.nlm.nih.gov
Introduction of immunotherapy (IT) has radically changed the therapeutic scenario in
patients affected by locally advanced and/or metastatic cutaneous squamous cell carcinoma …
patients affected by locally advanced and/or metastatic cutaneous squamous cell carcinoma …
Basal Cell Carcinoma—A Retrospective Descriptive Study Integrated in Current Literature
Basal cell carcinoma (BCC) is considered to be the most common cancer in humans. It has a
slow growth rhythm, and for this reason, metastases are rare. For our retrospective study, we …
slow growth rhythm, and for this reason, metastases are rare. For our retrospective study, we …
Overview of germline and somatic genetic alterations in basal and squamous cell carcinoma: a review of the current literature
S Mazzilli, P Chiara, G Costanza, A Petruzzellis… - European Journal of …, 2021 - Springer
Non-melanoma skin cancers (NMSCs), including basal and squamous cell carcinomas,
represent the most common malignancies among Caucasians. Over two million cases of …
represent the most common malignancies among Caucasians. Over two million cases of …
[HTML][HTML] Basal cell carcinoma and its impact on different anatomical regions
A Cojocaru, EA Marinescu, O Nica… - Current Health …, 2021 - ncbi.nlm.nih.gov
Basal cell carcinoma (BCC) is the most common skin cancer. We conducted a retrospective
study over a period of two years (2018-2019), on 214 patients from the Plastic Surgery clinic …
study over a period of two years (2018-2019), on 214 patients from the Plastic Surgery clinic …
Lack of association between the ACE2 G8790A gene variation and risk for basal cell carcinoma
I Gintoni, S Vassiliou, D Avgoustidis… - Anticancer …, 2021 - ar.iiarjournals.org
Abstract Background/Aim: The G8790A (rs2285666) functional polymorphism of the
angiotensin-converting enzyme 2 (ACE2) gene influences alternative mRNA splicing and …
angiotensin-converting enzyme 2 (ACE2) gene influences alternative mRNA splicing and …
[HTML][HTML] Reconstrucción nasal alar tridimensional por exéresis de carcinoma basocelular en paciente geriátrico
D Morales Navarro, V Barreto Orozco - Revista Cubana de …, 2019 - scielo.sld.cu
Objetivo: Caracterizar un caso de reconstrucción nasal alar tridimensional por exéresis de
carcinoma basocelular en paciente geriátrico. Caso clínico: Paciente masculino de 81 años …
carcinoma basocelular en paciente geriátrico. Caso clínico: Paciente masculino de 81 años …
Efficacy of dermoscopy in the diagnosis of different basal cell carcinoma subtypes
SK El-Sayed, GEDA El-Sayed, AM Kamel… - Egyptian Journal of …, 2020 - journals.lww.com
Background Basal cell carcinoma (BCC) accounts for nearly 80% of all nonmelanoma skin
cancers and dermoscopy is an important, noninvasive technique that aids in the diagnosis of …
cancers and dermoscopy is an important, noninvasive technique that aids in the diagnosis of …
What we need to learn when exploring the mixed basal cell carcinoma of head and neck
J Moisejenko-Goluboviča, O Volkovs… - Proceedings of the …, 2021 - sciendo.com
Coexistence of different histopathological types of basal cell carcinomas (BCC) in the same
anatomical localisation is rare, and, therefore, is engaging for histopathologists and …
anatomical localisation is rare, and, therefore, is engaging for histopathologists and …
A retrospective study comparing different injection approaches of 5-aminolevulinic acid in patients with non-melanoma skin cancer
W Zhao, J Wang, Y Zhang, B Zheng - Journal of Dermatological …, 2022 - Taylor & Francis
Background 5-aminolevulinic acid through a needle-free, plum-blossom needle or
conventional needle followed by photodynamic therapy are available options for non …
conventional needle followed by photodynamic therapy are available options for non …
Antecedente de grado de expresividad de p53 en carcinomas basocelulares como predictor de recurrencia
VS Freire - Revista Médica-Científica CAMbios HECAM, 2023 - revistahcam.iess.gob.ec
Resumen INTRODUCCIÓN. El gen Tp53 proporciona instrucciones para producir proteína
tumoral 53. El Tp53 es un gen supresor tumoral que protege el ciclo celular, reparando el …
tumoral 53. El Tp53 es un gen supresor tumoral que protege el ciclo celular, reparando el …